Rocket's Danon plans; Novo leaves Ascendis; Lilly's latest deal

Plus news about Corbus, Syntis, Arrowhead, BioMarin, BioVie, Agomab, Antelope Therapeutics, Connect Biopharma and Genfit. Rocket Pharmaceuticals aligns with FDA on Danon: The commercial-stage biotech said it reached alignment with the ...